ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1115

Prevalence Of Structural and Inflammatory Sacroiliitis, Assessed Using Computed Tomography and MR Imaging, In Inflammatory Bowel Disease: A Retrospective Study In 78 Patients

Sophie Leclerc-Jacob1, Guillaume Lux2, Anne Christine Rat1, Valérie Laurent2, Alain Blum2, Isabelle Chary-Valckenaere1, Laurent Peyrin-Biroulet3 and Damien Loeuille4, 1Rheumatology, Nancy Teaching Hospital, Nancy, France, 2Radiology, Nancy Teaching Hospital, Nancy, France, 3Gastroenterology and Hepatology, Nancy Teaching Hospital, Nancy, France, 4Rheumatology, CHU Brabois, Vandoeuvre les Nancy, France

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Computed tomography (CT), inflammatory bowel disease (IBD), Magnetic resonance imaging (MRI) and spondylarthropathy

  • Tweet
  • Email
  • Print
Session Information

Title: Imaging of Rheumatic Diseases II: Imaging in Spondyloarthritis and Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The primary objective was to assess the prevalence of structural and inflammatory sacroiliitis on computed tomography (CT) and MRI in inflammatory bowel disease (IBD). The secondary aim was to elucidate clinico-biological factors associated with the presence of sacroiliitis in patients with IBD.

Methods:

This study involved 78 patients suffering from IBD who were followed in a gastroenterology department between 2004 and 2011: 61 of them with Crohn’s disease (CD) (78.2%) and 17 with ulcerative colitis (UC) (21.8%). Clinico-biological, endoscopic and imaging (CT and MRI) data were collected during patient follow-up. Structural sacroiliitis was assessed from CT exams performed according to the modified New-York criteria for structural assessement. Inflammatory sacroiliitis was assessed on axial and coronal fat suppressed injected T1-weighted sequences according to ASAS (Assessment of SpondyloArthritis international Society) criteria. Both imaging modalities were scored blindly by two independent readers (a rheumatologist and a radiologist) and the diagnosis of sacroiliitis (structural and inflammatory) was established by consensus.

Results:

The prevalence of structural sacroiliitis was 14.1% (n=11) and that of inflammatory sacroiliitis 15.4% (n=12). On MRI, unilateral sacroiliitis was depicted in five cases and bilateral sacroiliitis in seven. The prevalence of sacroiliitis according to both imaging modalities was 28.2% (n=22). Sacroiliac joints (SIJ) were considered normal in 71.8% (n=56). Disease duration of IBD was significantly associated with the presence of structural sacroiliitis (p=0.01) on CT and inflammatory sacroiliitis (p=0.02) on MRI. Others factors such as gender, age, type of IBD, localization of IBD, surgery history, biological inflammation, bowel disease activity and treatment were not associated with sacroiliitis.

Conclusion:

Structural or inflammatory sacroiliitis was revealed by CT or MRI in 28.2% of patients suffering from IBD. These imaging methods have a complementary role in establishing a diagnosis of sacroiliitis and contributing to an earlier diagnosis of axial spondylarthritis.


Disclosure:

S. Leclerc-Jacob,
None;

G. Lux,
None;

A. C. Rat,
None;

V. Laurent,
None;

A. Blum,
None;

I. Chary-Valckenaere,
None;

L. Peyrin-Biroulet,
None;

D. Loeuille,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-structural-and-inflammatory-sacroiliitis-assessed-using-computed-tomography-and-mr-imaging-in-inflammatory-bowel-disease-a-retrospective-study-in-78-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology